These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26669906)

  • 1. Stimuli-Responsive Shapeshifting Mesoporous Silica Nanoparticles.
    Sun Y; Sai H; Spoth KA; Tan KW; Werner-Zwanziger U; Zwanziger J; Gruner SM; Kourkoutis LF; Wiesner U
    Nano Lett; 2016 Jan; 16(1):651-5. PubMed ID: 26669906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicompartment mesoporous silica nanoparticles with branched shapes: an epitaxial growth mechanism.
    Suteewong T; Sai H; Hovden R; Muller D; Bradbury MS; Gruner SM; Wiesner U
    Science; 2013 Apr; 340(6130):337-41. PubMed ID: 23599490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enlarged Pore Size Chiral Mesoporous Silica Nanoparticles Loaded Poorly Water-Soluble Drug Perform Superior Delivery Effect.
    Guo Y; Gou K; Yang B; Wang Y; Pu X; Li S; Li H
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31575047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of mesoporous hollow silica nanospheres using polymeric micelles as template and their application as a drug-delivery carrier.
    Sasidharan M; Zenibana H; Nandi M; Bhaumik A; Nakashima K
    Dalton Trans; 2013 Oct; 42(37):13381-9. PubMed ID: 23887599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Peptide Functionalization on Mesoporous Silica Nanoparticles for Controlled Drug Release.
    Hu JJ; Xiao D; Zhang XZ
    Small; 2016 Jul; 12(25):3344-59. PubMed ID: 27152737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer.
    Li T; Shi S; Goel S; Shen X; Xie X; Chen Z; Zhang H; Li S; Qin X; Yang H; Wu C; Liu Y
    Acta Biomater; 2019 Apr; 89():1-13. PubMed ID: 30797106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
    Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
    Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights towards mesoporous silica nanoparticles as a technological platform for chemotherapeutic drugs delivery.
    Sábio RM; Meneguin AB; Ribeiro TC; Silva RR; Chorilli M
    Int J Pharm; 2019 Jun; 564():379-409. PubMed ID: 31028801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesoporous silica nanoparticles in nanomedicine applications.
    Manzano M; Vallet-Regí M
    J Mater Sci Mater Med; 2018 May; 29(5):65. PubMed ID: 29737405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-Pot Synthesis of Aminated Bimodal Mesoporous Silica Nanoparticles as Silver-Embedded Antibacterial Nanocarriers and CO
    Li Y; Tiwari AK; Ng JS; Seah GL; Lim HK; Suteewong T; Tay CY; Lam YM; Tan KW
    ACS Appl Mater Interfaces; 2022 Nov; 14(46):52279-52288. PubMed ID: 36375117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T; Geng T; Md A; Banerjee P; Wang B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery.
    Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ
    Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook.
    Song Y; Li Y; Xu Q; Liu Z
    Int J Nanomedicine; 2017; 12():87-110. PubMed ID: 28053526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-Time Monitoring of ATP-Responsive Drug Release Using Mesoporous-Silica-Coated Multicolor Upconversion Nanoparticles.
    Lai J; Shah BP; Zhang Y; Yang L; Lee KB
    ACS Nano; 2015 May; 9(5):5234-45. PubMed ID: 25859611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
    Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
    J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and Controllability of Mesoporous Silica Nanoparticles.
    Yamamoto E; Kuroda K
    Enzymes; 2018; 44():1-10. PubMed ID: 30360809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionalized mesoporous silica nanoparticles with redox-responsive short-chain gatekeepers for agrochemical delivery.
    Yi Z; Hussain HI; Feng C; Sun D; She F; Rookes JE; Cahill DM; Kong L
    ACS Appl Mater Interfaces; 2015 May; 7(18):9937-46. PubMed ID: 25902154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox-responsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers.
    Wang Y; Han N; Zhao Q; Bai L; Li J; Jiang T; Wang S
    Eur J Pharm Sci; 2015 May; 72():12-20. PubMed ID: 25701727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.